Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders

Archive ouverte

Maioli, Tatiani | Borras-Nogues, Esther | Torres, Licia | Barbosa, Sara | Martins, Vinicius | Langella, Philippe | Azevedo, Vasco | Chatel, Jean-Marc

Edité par CCSD ; Frontiers -

International audience. Metabolic disorders are an increasing concern in the industrialized world. Current research has shown a direct link between the composition of the gut microbiota and the pathogenesis of obesity and diabetes. In only a few weeks, an obesity-inducing diet can lead to increased gut permeability and microbial dysbiosis, which contributes to chronic inflammation in the gut and adipose tissues, and to the development of insulin resistance. In this review, we examine the interplay between gut inflammation, insulin resistance, and the gut microbiota, and discuss how some probiotic species can be used to modulate gut homeostasis. We focus primarily on Faecalibacterium prausnitzii, a highly abundant butyrate-producing bacterium that has been proposed both as a biomarker for the development of different gut pathologies and as a potential treatment due to its production of anti-inflammatory metabolites.

Suggestions

Du même auteur

Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii

Archive ouverte | Auger, Sandrine | CCSD

International audience. The commensal bacterium Faecalibacterium prausnitzii has unique anti-inflammatory properties, at least some of which have been attributed to its production of MAM, the Microbial Anti-inflamma...

New Insights into the Diversity of the Genus Faecalibacterium

Archive ouverte | Benevides, Leandro | CCSD

International audience

Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP

Archive ouverte | Carvalho, Rodrigo | CCSD

International audience. Mucositis is an inflammatory condition of the gut, caused by an adverse effect of chemotherapy drugs, such as 5-fluorouracil (5-FU). In an attempt to develop alternative treatments for the di...

Chargement des enrichissements...